Ceva Animal Health is a global company focused on technical product innovation and delivering high quality products to swine veterinarians and pig producers.
Forceris® A single action for a healthy start is one such innovative product. The first combined gleptoferron + toltrazuril product for convenient on farm use.
Ceva’s extensive vaccine portfolio includes Hyogen® and Coglapix®, our Mycoplasma and App vaccines, as well as Circovac® for PCV and Progressis® for PRRS. Ceva also provides a full vaccine solution for swine influenza with Respiporc Flu3® and Respiporc FLUPan®. Specialised Salmoporc® and Ecoporc Shiga® vaccines complete the range.
The highly recognisable Altresyn®, Gleptosil® and Pracetam® brands complete the swine product portfolio.
Interactive support services such as the Ceva Lung Program (CLP) for detailed analysis of respiratory health and the Ceva Reproductive Program (CRP) which allows accurate monitoring of whole herd efficiency and economics, deliver additional value and product support to both vets and pig producers.
Boehringer Ingelheim Animal Health believes that the value of an animal health company goes beyond the products they sell. It’s the industry knowledge, technical support and customised solutions they bring that really help improve overall production and profitability.
Prevention Works is a holistic approach to swine health built on our range of innovative, world-class vaccines complemented by:
Global expertise combined with local knowledge
State-of-the-art diagnostics and support
Tools to evaluate the success of prevention
Ultimately we are committed to providing the unique knowledge, products and support services producers and veterinarians need to minimise disease transmission, maximise immune response and optimise profitability; helping to shape the future of Swine Health.
For further information please visit: www.preventionworks.info
Further information is available from Boehringer Ingelheim Animal Health UK Ltd, Bracknell, Berkshire, RG12 8YS, UK. Email: firstname.lastname@example.org.
Use Medicines Responsibly (www.noah.co.uk/responsible)
Cargill helps the world’s food system work for you. We connect farmers with markets, customers with ingredients and families with daily essentials—from the foods they eat to the floors they walk on. Our 155,000 team members around the world innovate with purpose, empowering our partners and communities as we work to nourish the world in a safe, responsible, sustainable way.
From feed that reduces methane emissions to waste-based renewable fuels, the possibilities are boundless. But our values remain the same. We put people first. We reach higher. We do the right thing. It’s how we’ve met the needs of the people we call neighbours and the planet we call home for 157 years—and how we’ll do so for generations to come. For more information, visit Cargill.com and our News Center.
Elanco is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals, creating value for farmers, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities.
Elanco wishes to advise on appropriate strategies to overcome post-weaning diarrhoea (PWD), by offering free diagnostics ahead of the removal of zinc oxide. Coliprotec™ immunises young pigs, from as early as 18 days of age, against enterotoxigenic F4 and F18 Escherichia coli, the main cause of PWD. Elanco is also supporting producers in overcoming escalating feed prices. Hemicell™ XT is an energy sparing enzyme for inclusion in feed rations to improve Intestinal Integrity, growth and production efficiency. Hemicell XT acts to prevent the feed-induced immune response (FIIR) to ß-mannans which are anti-nutritive fibres commonly found in swine feeds. Learn more at MyElanco.co.uk.
As the world’s leading animal health company, we are driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, we continue to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners. The company’s leading portfolio and pipeline of medicines, vaccines, diagnostics, and technologies make a difference in over 100 countries. A Fortune 500 company, we generated revenue of $7.8 billion in 2021 with ~12,100 employees. For more information, visit www.zoetis.co.uk